A Roundup of This Week's #CureFacts

The biologics license application seeks potential approval of a Darzalex Faspro-based regimen for newly diagnosed multiple myeloma ineligible for transplant.

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.

Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

As a survivor of acute myeloid leukemia, some things are no longer going to be normal, but who wants to be normal?

From good news for a rock star to the deaths of stage and screen stars, here’s what’s happening in the cancer space this week.